about
Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemiaOsteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Identification of transglutaminase reactive residues in human osteopontin and their role in polymerizationPolymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding sitePlasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.Transglutaminase regulation of cell function.Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretionsA novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.Pre- and post-translational regulation of osteopontin in cancer.Separation of newly formed bone from older compact bone reveals clear compositional differences in bone matrixTissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line.Osteopontin and wound healing in bone.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Transglutaminase 2 as a biomarker of osteoarthritis: an update.Substrates of Factor XIII-A: roles in thrombosis and wound healing.The role of nanoscale toughening mechanisms in osteoporosis.Crystallization and preliminary X-ray crystallographic studies of transglutaminase 2 in complex with Ca2+.Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity.Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides.Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoproteinCellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in OsteoblastsEnhanced biological activity of polymeric osteopontin.Expression and localization of plasma transglutaminase factor XIIIA in bone.External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.Cross-linked matrix rigidity and soluble retinoids synergize in nuclear lamina regulation of stem cell differentiationImportance of phosphorylation for osteopontin regulation of biomineralization.Mathematical model for bone mineralization.Elevated expression of isopeptide bond cross-links contributes to fibrosis in scleroderma and the healing wounds of tight skin mice.Calcospherulites isolated from the mineralization front of bone induce the mineralization of type I collagen.Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.Transglutaminases: future perspectives.Mineralization of dense collagen hydrogel scaffolds by human pulp cells.Is osteoporosis an autoimmune mediated disorder?Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
P2860
Q27002346-8086F9C2-143B-4E70-84EC-DDA66B142294Q28509843-39691F58-2F28-4520-9C78-CBCF0BFCFF28Q28651507-44470D4B-AF95-42A9-8CFF-9FFA00829A7DQ30487764-A19855F8-3C78-4721-9738-497CC95EE568Q30997344-B3711BB2-2099-4BA3-B1D9-43D2A271F8CEQ33707936-7743D228-6294-428B-AD96-2B6DB8944682Q34059572-A4BD61E5-FE85-457B-B2FF-59B9CC06D6E5Q34784777-B234B2EB-F40B-4AF4-BED8-E26AD222D9E9Q34939938-5F7BA940-E71E-4394-8579-EC937F54D41CQ35566336-053E8F64-25D1-495F-BC4A-8BEB99DE0D67Q37371043-59279EE0-2494-4E05-B2B2-765E72EF0AEAQ37876085-FC342927-9D9F-4A14-ACAD-E35EF978328CQ37899674-16EB20A2-52E0-4E67-A52E-6AAECF3703CCQ37964507-6C585996-9ED7-4CDA-8AF0-B860DA91B149Q38052936-4CA7B61B-553F-4E71-87D8-29AA426CAE0DQ38223620-9CBFC5D6-4D43-4730-9E67-F5252183ACE2Q38618937-7C003D43-5F2F-4825-BC95-A8218F6B0399Q39414447-D8DA908B-C01F-49D8-9159-2D88599D3A65Q39449371-C6692777-5996-4827-8BB6-912631614300Q39652140-2FF2C6FB-7A56-4AB3-A2FD-71E37EFCC83DQ39657548-262D5D46-418A-4555-A8C0-F9987F45849EQ40127298-377A9BE8-A300-48B3-9D60-F3B296638A88Q40162733-BC5AD0B6-EBBA-45CF-ACA0-FA5A80973C65Q40462021-6719ACB3-9B36-49D6-AB51-CAA996E50406Q41230121-A2B483E5-C4C9-4FDD-BE8A-955F30000C94Q41862328-B8BBD964-993B-4F2D-B07C-1F081906075AQ42209855-0464092D-E20A-4BA9-9978-835893751529Q42272522-0392384C-2DED-42B8-9B90-64769D0095CFQ43029105-55E57D1B-03A3-4005-ABE3-E2845F4AAFD4Q44329023-9525355F-B546-4620-8726-1C53CCC26140Q44811427-7A766766-72C9-4EC5-AC94-5474CDF35A16Q46288259-A5329AB2-9195-4528-B847-4B4CB13413C5Q47097021-E6DF58FD-8998-4F87-9995-C35BBE16F19DQ47357582-CF5E6C1D-2D61-4CCD-ABAC-45A8AE6A9983Q48305796-ACAA3FDB-E43E-41B9-A64E-03AE6ECD7C17Q51673654-0AA47E4A-1C24-4B1A-AAC7-2850A1673691Q55499802-889C9424-8F16-46C0-94E3-B32C9CE6EB27
P2860
description
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Dezember 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/12/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/12/01)
@nl
наукова стаття, опублікована в грудні 2002
@uk
مقالة علمية (نشرت في ديسمبر 2002)
@ar
name
Tissue transglutaminase and its substrates in bone
@ast
Tissue transglutaminase and its substrates in bone
@en
Tissue transglutaminase and its substrates in bone
@nl
type
label
Tissue transglutaminase and its substrates in bone
@ast
Tissue transglutaminase and its substrates in bone
@en
Tissue transglutaminase and its substrates in bone
@nl
prefLabel
Tissue transglutaminase and its substrates in bone
@ast
Tissue transglutaminase and its substrates in bone
@en
Tissue transglutaminase and its substrates in bone
@nl
P2093
P1476
Tissue transglutaminase and its substrates in bone
@en
P2093
Marc D McKee
Niina H Räsänen
Sherif El-Maadawy
P2860
P304
P356
10.1359/JBMR.2002.17.12.2161
P577
2002-12-01T00:00:00Z